December 3, 2017
Two full-time University of California San Diego faculty members — Don Cleveland, who studies fundamental cellular mechanisms in the search for new treatments for diseases like amyotrophic lateral sclerosis (ALS), and James McKernan, a mathematician who investigates algebraic geometry and multivariate polynomials — are recipients of the 2018 Breakthrough Prize,…
November 19, 2020
…help to prevent large antibody molecules from binding to the enzyme. The researchers’ findings, published in Biophysical Journal, likely apply more generally—including to the SARS-CoV-2 virus that causes COVID-19. Amaro will soon be releasing new findings about her latest research on the virus’ spike protein. Zeroing in on glycans and…
October 15, 2015
…a large-scale and generating antibodies that target transporter proteins. In addition, CROPS researchers will determine molecular structures of key plant membrane transporters and their natural variants, providing a new framework for understanding how transporters function and contribute to agriculturally important crop traits. “Food and health are interrelated,” said Chang. “By…
November 27, 2018
Seven researchers at the University of California San Diego have been named Fellows of the American Association for the Advancement of Science (AAAS), the largest general science organization in the United States and publisher of the journal Science.
July 23, 2020
…uses a bispecific monoclonal antibody—an artificial protein that binds to two different types of antigen—to engage multiple T-cell targets simultaneously with the intent of making combination immunotherapies more effective. “UC San Diego Health stepped up and made sure I got the next best thing,” said Thurman. “It’s literally a matter…
June 17, 2020
Nanoparticles cloaked in human lung cell membranes and human immune cell membranes can attract and neutralize the SARS-CoV-2 virus in cell culture, causing the virus to lose its ability to hijack host cells and reproduce.
September 23, 2016
Prof. Sahoo – whose journey into the world of cancer genomics was borne from his background in computer science – has been selected as a participating member of the Cancer Genomes and Networks program at UC San Diego Moores Cancer Center.
April 16, 2020
…are focused on designing antibodies to prevent the virus from binding to a cell and then running simulations to determine their success. Others are tinkering with solutions to keep the coronavirus from replicating itself, in the event that it does infect a human cell. All of this represents potential movement…
October 23, 2014
…that unlike Zmapp, whose antibodies must be grown in a plant model, a time-consuming process, the manufacture of brincidofovir is comparatively quick and easily scaled up. Second, brincidofovir has been clinically tested on more than 1,000 human subjects, many of whom were desperately ill, and many of whom were children.…
June 9, 2022
An international team of researchers, led by scientists at University of California San Diego School of Medicine and the University of Pittsburgh, report promising results from the largest case series yet of patients treated with bacteriophage therapy for antibiotic-resistant infections.
